Incyte
INCY
#983
Rank
HK$185.17 B
Marketcap
HK$908.48
Share price
-1.64%
Change (1 day)
15.16%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): HK$16.35

According to Incyte's latest financial reports the company's current EPS (TTM) is HK$16.47. In 2025 the company made an earnings per share (EPS) of HK$51.75 an increase over its 2024 EPS that were of HK$2.43.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$16.35-68.4%
2025HK$51.752029.03%
2024HK$2.43-88.39%
2023HK$20.9373.38%
2022HK$12.07-64.1%
2021HK$33.64-408.63%
2020-HK$10.90-166.83%
2019HK$16.31300%
2018HK$4.08-133.33%
2017-HK$12.23-378.57%
2016HK$4.392700%
2015HK$0.16-106.67%
2014-HK$2.35-44.44%
2013-HK$4.2350%
2012-HK$2.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.16 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-66.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.20 1,370.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.27 727.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$20.31 23.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.63-103.81%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$4.55-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$6.59-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.72-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA